Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Novartis heart failure medicine Entresto wins EU approval

Wednesday, November 25, 2015

The European Commission has approved Novartis Entresto drug for the treatment of adult patients with symptomatic chronic heart failure with reduced ejection fraction the Swiss drugmaker said on Tuesday Entresto is the first new drug in decades for h...

WuXi PharmaTech announces shareholders' approval of Merger Agreement

Wednesday, November 25, 2015

WuXi PharmaTech Inc a leading openaccess RD capability and technology platform company serving the pharmaceutical biotechnology and medical device industries with operations in China and the United States today announced that at an extraordinary gene...

CVS chooses Amgen's new cholesterol drug over competitor

Tuesday, November 24, 2015

US drug benefit manager CVS Health said on Monday that it would add Amgen Incs Repatha cholesterol treatment to its list of covered drugs for private plans over a competing treatment from Sanofi SA and Regeneron Pharmaceuticals The two competing tre...

Bristol-Myers signs deal with U.N. group for generic hepatitis C drug

Tuesday, November 24, 2015

A United Nationsbacked organization working to cut the price of HIV drugs said it had signed a deal with BristolMyers Squibb Co to allow generic versions of the companys hepatitis C drug to be sold in low and middleincome countries The drug Daklinz...

Novartis' Cosentyx receives European nod to treat ankylosing spondylitis & psoriatic arthritis

Tuesday, November 24, 2015

The European Commission EC has approved Novartis Cosentyx secukinumab for the treatment of people living with ankylosing spondylitis AS and psoriatic arthritis PsA For AS this is the first new treatment advance in years since the development of the...

AstraZeneca sells U.S. drug rights to Perrigo for $380 million

Tuesday, November 24, 2015

AstraZeneca said on Monday it had finalised plans to divest its Crohns disease drug Entocort by selling US rights to the medicine to Perrigo PRGON for million The move is part of an externalization drive by the British drugmaker which is selling no...

Strides Shasun gets USFDA nod to market Dutasteride capsules

Monday, November 23, 2015

Strides Shasun has received approval from the US health regulator to market Dutasteride capsules used in treating enlarged prostate gland in the American market The company has received approval from the US Food and Drug Administration USFDA to mark...

Aurobindo Pharma gains after receiving USFDA approval for Sildenafil Tablets

Monday, November 23, 2015

Aurobindo Pharma rose to Rs at IST on BSE after the company said that it has received final approval from the United States Food and Drug Administration to manufacture and market Sildenafil Tablets mg The company made announcement on Saturday N...

Pfizer set to buy Allergan for more than $150 billion

Monday, November 23, 2015

Pfizer Inc was due to secure formal board approval on Sunday for its acquisition of Botox maker Allergan Plc AGNN for more than billion creating the worlds biggest drug maker according to people familiar with the matter The deal the largest ever in...

Novartis gets FDA approval for skin cancer drug combination

Saturday, November 21, 2015

Novartis AG said on Friday it received the US Food and Drug Administrations regular approval for a drug combination to treat an aggressive form of skin cancer The FDA approved Tafinlar and Mekinist for treatment of metastatic melanoma based on two y...